Introductory text

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community,

Having regard to Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff^f1, as last amended by Regulation (EEC) No 1667/93^f2, and in particular Article 9 thereof,

Whereas Regulation (EEC) No 2658/87 established the nomenclature of goods, hereinafter referred to as the combined nomenclature, which serves the purposes both of the Community's Common Customs Tariff and of its external trade statistics;

Whereas in order to ensure uniform application of the combined nomenclature, it is necessary to adopt provisions concerning the classification of halogenated derivatives of adrenal cortical hormones of CN code 2937 22 00; whereas an additional note to this effect should be inserted in Chapter 29 of the combined nomenclature; whereas Regulation (EEC) No 2658/87 should be amended accordingly;

Whereas the present Regulation is relevant to the product ‘mometazone furoate (INNM)’, listed as the second product in the Annex to Commission Regulation (EEC) No 3565/88^f3; whereas, in consequence, the latter Regulation should be amended accordingly;

Whereas the provisions of this Regulation are in accordance with the opinion of the Nomenclature Committee,

HAS ADOPTED THIS REGULATION: